Tony AVRIL
Tony AVRIL
PROSAC - INSERM COSS U1242 - Centre Eugène Marquis - Rennes
Adresse e-mail validée de rennes.unicancer.fr
TitreCitée parAnnée
Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec‐7‐dependent and‐independent mechanisms
G Nicoll, T Avril, K Lock, K Furukawa, N Bovin, PR Crocker
European journal of immunology 33 (6), 1642-1648, 2003
1722003
The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and-9, CD33-related Siglecs expressed on …
T Avril, H Floyd, F Lopez, E Vivier, PR Crocker
The Journal of Immunology 173 (11), 6841-6849, 2004
1482004
Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Rα2, gp100 and TRP-2 for immunotherapy
S Saikali, T Avril, B Collet, A Hamlat, JY Bansard, B Drenou, Y Guegan, ...
Journal of neuro-oncology 81 (2), 139-148, 2007
1242007
Overview of cellular immunotherapy for patients with glioblastoma
E Vauleon, T Avril, B Collet, J Mosser, V Quillien
Clinical and Developmental Immunology 2010, 2010
1122010
Sialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharides
T Avril, ER Wagner, HJ Willison, PR Crocker
Infection and immunity 74 (7), 4133-4141, 2006
1122006
Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism
T Avril, AC Jarousseau, H Watier, J Boucraut, P Le Bouteiller, P Bardos, ...
The Journal of Immunology 162 (10), 5902-5909, 1999
1091999
Siglec-5 (CD170) can mediate inhibitory signaling in the absence of immunoreceptor tyrosine-based inhibitory motif phosphorylation
T Avril, SD Freeman, H Attrill, RG Clarke, PR Crocker
Journal of Biological Chemistry 280 (20), 19843-19851, 2005
872005
Endoplasmic Reticulum Stress and the Hallmarks of Cancer
H Urra, E Dufey, T Avril, E Chevet, C Hetz
Trends in Cancer 2 (5), 252-262, 2016
812016
Human Glioblastoma Stem‐Like Cells are More Sensitive to Allogeneic NK and T Cell‐Mediated Killing Compared with Serum‐Cultured Glioblastoma Cells
T Avril, E Vauleon, A Hamlat, S Saikali, A Etcheverry, C Delmas, S Diabira, ...
Brain Pathology 22 (2), 159-174, 2012
652012
Probing the cis interactions of the inhibitory receptor Siglec‐7 with α2,8‐disialylated ligands on natural killer cells and other leukocytes using glycan‐specific …
T Avril, SJ North, SM Haslam, HJ Willison, PR Crocker
Journal of leukocyte biology 80 (4), 787-796, 2006
622006
Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2, 3-dioxygenase (IDO) on tumour-specific T cell functions
T Avril, S Saikali, E Vauléon, A Jary, A Hamlat, M De Tayrac, J Mosser, ...
Journal of neuroimmunology 225 (1-2), 22-33, 2010
602010
Differential analysis of glioblastoma multiforme proteome by a 2D-DIGE approach
B Collet, N Guitton, S Saïkali, T Avril, C Pineau, A Hamlat, J Mosser, ...
Proteome science 9 (1), 16, 2011
422011
Negative regulation of leucocyte functions by CD33-related siglecs
T Avril, H Attrill, J Zhang, A Raper, PR Crocker
Biochemical Society Transactions 34 (6), 1024-1027, 2006
422006
Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures
S Eimer, F Dugay, K Airiau, T Avril, V Quillien, MA Belaud-Rotureau, ...
Neuro-Oncology, 2012
412012
Endoplasmic reticulum proteostasis in glioblastoma—From molecular mechanisms to therapeutic perspectives
J Obacz, T Avril, PJ Le Reste, H Urra, V Quillien, C Hetz, E Chevet
Sci. Signal. 10 (470), eaal2323, 2017
382017
Isolation of a new cell population in the glioblastoma microenvironment
A Clavreul, A Etcheverry, A Chassevent, V Quillien, T Avril, ML Jourdan, ...
Journal of neuro-oncology 106 (3), 493-504, 2012
352012
Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers
T Avril, E Vauleon, E Chevet
Oncogenesis 6 (8), e373, 2017
342017
Glioblastoma‐associated stromal cells (GASCs) from histologically normal surgical margins have a myofibroblast phenotype and angiogenic properties
A Clavreul, C Guette, R Faguer, C Tétaud, A Boissard, L Lemaire, ...
The Journal of pathology 233 (1), 74-88, 2014
342014
Mechanisms of immunomodulation in human glioblastoma
T Avril, E Vauleon, S Tanguy-Royer, J Mosser, V Quillien
Immunotherapy 3 (4s), 42-44, 2011
342011
Dual IRE1 RNase functions dictate glioblastoma development
S Lhomond, T Avril, N Dejeans, K Voutetakis, D Doultsinos, M McMahon, ...
EMBO molecular medicine 10 (3), e7929, 2018
262018
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20